Charles M. Rudin

3 ta ish

Memorial Sloan Kettering Cancer Center

1. A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

   Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière +27

   MaqolaOAOchiq kirish20213 iqtibos

   ABIABI:AkademIndex/2026.other.102892

2. IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models

   Janneke E. Jaspers, Jonathan F. Khan, William D. Godfrey +4

   MaqolaOAOchiq kirish20232 iqtibos

   ABIABI:AkademIndex/2026.other.102936

3. Small-cell lung cancer

   Charles M. Rudin, Élisabeth Brambilla, Corinne Faivre‐Finn +1

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.560997